In line with these previous findings, we revealed that PELI1 acts as an E3 ubiquitin ligase of EGFR to enhance the recycling of EGFR, which accounts for its aberrant expression in triple-negative breast cancers. Here, EGFR is linked to triple-negative breast carcinoma.